Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Pfizer PFE Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-625,951	Closed	-$18.1M	–	56
2024 Q3	$18.1M	Buy	625,951 +625,898	+1,180,940%	+$18.3M	2.51%	19
2024 Q2	$1.48K	Hold	53	–	–	﹤0.01%	41
2024 Q1	$1.47K	Hold	53	–	–	﹤0.01%	37
2023 Q4	$1.53K	Sell	53 -447,480	-100%	-$13.5M	﹤0.01%	31
2023 Q3	$14.8M	Buy	447,533 +762	+0.2%	+$26.9K	4.69%	11
2023 Q2	$16.4M	Buy	446,771 +266,566	+148%	+$10.4M	4.76%	9
2023 Q1	$7.35M	Sell	180,205 -17,313	-9%	-$748K	2.6%	16
2022 Q4	$10.1M	Hold	197,518	–	–	4.4%	11
2022 Q3	$8.64M	Buy	+197,518	New	+$9.6M	4.08%	15

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's PFE Position: Q4 2024 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of Pfizer (PFE) in Q4 2024, closing a stake of 625,951 shares — an estimated $18.1M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in PFE in Q3 2022 and held it in 9 quarters. The position peaked at $18.1M in Q3 2024. 2,997 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 625,951 Pfizer shares in Q4 2024, an estimated $18.1M.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Pfizer in Q3 2022 and held it in 9 quarters.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Pfizer position peaked at $18.1M in Q3 2024.
2,997 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q4 2024, filed 18 Feb 2025.